It is axiomatic that the intracellular degradation of any protein must involve a sequential series of proteolytic events leading ultimately to the conversion of a functionally competent protein into its component amino acids : the 'catabolic sequence'. Although our understanding of intracellular protein catabolism is improving, the catabolic sequence has not been described for a single intracellular protein. The major restriction in defining the intermediates in the degradation of any protein is the lack of specificity of the labels that are normally used. Radiolabelled amino acids are incorporated into all proteins ; subsequent proteolysis results in a highly heterogeneous pool of degradation peptides that are labelled uniformly and which cannot be distinguished.
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Clearly, there is a need for a specific label that could be used to trace the fate of a particular protein, or part of a protein molecule, during the catabolic process. Such a label should fulfil several criteria. (1) It should be incorporated exclusively into a single protein species. (2) It should be readily detectable, preferably by more than one method to allow cross checking. (3) It should be intrinsic to the target protein, 'physiologically acceptable' and should not modify the structure (or proteolytic susceptibility) of the protein beyond normal limits. (4) It should remain associated with the degradation products during catabolism.
We have been studying the degradation of glycogen phosphorylase, and in particular have been investigating the suitability of the cofactor, pyridoxal phosphate, as a turnover label. More than 95% of the pyridoxal phosphate in skeletal muscle is associated with phosphorylase (Krebs & Fischer, 1966) , satisfying the requirement for specificity. Pyridoxal phosphate is readily detectable by a sensitive fluorescent assay of the cyanide adduct (Bonavita, 1960) or by scintillation counting of radiolabelled cofactor, and satisfies the criterion of being an intrinsic part of the enzyme. Thus, the applicability of pyridoxal phosphate as a specific label for phosphorylase was pivotal upon the persistence of the label. Phosphorylase binds to its cofactor via a covalent Schiff base extremely tightly (Fischer et al.,  1971 ). As part of this study, we have investigated the kinetics of exchange of labelled B6 vitamers in vim.
Male C57BL/6J mice were injected subcutaneously with 1OOpCi of [3H]pyridoxine and at various times afterwards animals were killed and the radioactivity was determined in blood and homogenates of skeletal muscle (protein bound and intracellular free pools; separated by Sephadex G-25). The blood pool disappeared over 4-5 days and was followed by the intracellular free pool with a lag period of approx. 1 day. By contrast, the protein-bound pool rose slowly but declined at a low rate such that a high degree of labelling was measurable (150000 c.p.m./g wet wt. of muscle) when the intracellular free pool had declined to zero.
High-performance .gel-permeation chromatography on TSK 3000 showed that the major peak of radioactivity in skeletal muscle was associated with phosphorylase and that all (> 98%) of the pyridoxal phosphate also eluted in this position. Pyridoxal phosphate appears to label phosphory- Time (days) Fig. 1 . Decay of pyridoxal phosphate-labelled phosphorylase in vivo Mice (C57BL/6J, male, 25g) were injected with lOOpCi of [3H]pyridoxine. After 4 days, animals were killed at various times; a 5 vol. skeletal muscle homogenate was prepared and was centrifuged at 78000g-h. The radioactivity associated with the protein-bound pool was determined by separation of the high-speed supernatant on Sephadex G-25. Each point represents a single animal; the line is the least-squares best-fit of a single exponential to the data. lase very specifically in skeletal muscle, reflecting the high concentration of the enzyme and the tightness of the association between the enzyme and its cofactor.
A second group of mice were injected with [ ' H Ipyridoxine and after a period of 4 days (to allow the intracellular free pool to decline) animals were killed and the decay in protein-bound radioactivity (i.e. phosphorylase) was determined (Fig. 1) . The loss of labelled protein was exponential yielding a rate constant of 0.06 day-I . If the loss of pyridoxal phosphate-labelled material represents proteolysis in vim this yields a half life of 11.1 days.
Preliminary data have shown that pyridoxal phosphate remains associated with degradation products during proteolysis of the enzyme in vitro. If this observation is reflected in vim pyridoxal phosphate may provide a novel method to label degradation products and identify the route of catabolism of a major skeletal muscle protein.
